AAAAAA
Results:
1-24
|
Results: 24
Authors:
Pirenne, J
Van Gelder, F
Coosemans, W
Aerts, R
Gunson, B
Koshiba, T
Fourneau, I
Mirza, D
Van Steenbergen, W
Fevery, J
Nevens, F
McMaster, P
Citation: J. Pirenne et al., Type of donor aortic preservation solution and not cold ischemia time is amajor determinant of biliary strictures after liver transplantation, LIVER TRANS, 7(6), 2001, pp. 540-545
Authors:
Pirenne, J
Aerts, R
Yoong, K
Gunson, B
Koshiba, T
Fourneau, I
Mayer, D
Buckels, J
Mirza, D
Roskams, T
Elias, E
Nevens, F
Fevery, J
McMaster, P
Citation: J. Pirenne et al., Liver transplantation for polycystic liver disease, LIVER TRANS, 7(3), 2001, pp. 238-245
Authors:
Aertgeerts, B
Buntinx, F
Ansoms, S
Fevery, J
Citation: B. Aertgeerts et al., Screening properties of questionnaires and laboratory tests for the detection of alcohol abuse or dependence in a general practice population, BR J GEN PR, 51(464), 2001, pp. 206
Authors:
Aziz, S
Kotal, P
Leroy, P
Servaes, R
Eggermont, E
Fevery, J
Citation: S. Aziz et al., Bilirubin-IX alpha and -IX beta pigments, coproporphyrins and bile acids in meconium and stools from full-term and preterm neonates during the first month of life, ACT PAEDIAT, 90(1), 2001, pp. 81-87
Authors:
Aziz, S
Leroy, P
Servaes, R
Eggermont, E
Fevery, J
Citation: S. Aziz et al., Bilirubin-IX beta is a marker of meconium, like zinc coproporphyrin, J PED GASTR, 32(3), 2001, pp. 287-292
Authors:
Pirenne, J
Aerts, R
Yoong, K
Gunson, B
Koshiba, T
Fourneau, I
Roskams, T
Elias, E
Nevens, F
Fevery, J
Mayer, D
Buckels, J
Mirza, D
McMaster, P
Citation: J. Pirenne et al., Surgical strategy in liver transplantation for polycystic liver disease, TRANSPLAN P, 33(1-2), 2001, pp. 1364-1365
Authors:
Pirenne, J
Aerts, R
Koshiba, T
Van Gelder, F
Roskams, T
Nevens, F
Fevery, J
Citation: J. Pirenne et al., Standard cyclosporine A-based versus completely steroid-free FK506-based immunosuppression after liver transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1505-1505
Authors:
Maes, BD
van Pelt, JF
Peeters, JC
Nevens, F
Evenepoel, P
Kuypers, D
Messiaen, T
Fevery, J
Vanrenterghem, YFC
Citation: Bd. Maes et al., The effect of mycophenolate mofetil on hepatitis B viral load in stable renal transplant recipients with chronic hepatitis B, TRANSPLANT, 72(6), 2001, pp. 1165-1166
Authors:
Van Roey, G
Fevery, J
Van Steenbergen, W
Citation: G. Van Roey et al., Hepatocellular carcinoma in Belgium: clinical and virological characteristics of 154 consecutive cirrhotic and non-cirrhotic patients, EUR J GASTR, 12(1), 2000, pp. 61-66
Authors:
Fevery, J
Nevens, F
Citation: J. Fevery et F. Nevens, Oesophageal varices: Assessment of the risk of bleeding and mortality, J GASTR HEP, 15(8), 2000, pp. 842-848
Authors:
van der Merwe, SW
Attfield, D
Fevery, J
van den Bogaerde, JB
Citation: Sw. Van Der Merwe et al., Hepatic osteodystrophy: the influence of liver disease and portal hypertension on cytokine activation, MED HYPOTH, 54(5), 2000, pp. 842-845
Authors:
Vitek, L
Kotal, P
Jirsa, M
Malina, J
Cerna, M
Chmelar, D
Fevery, J
Citation: L. Vitek et al., Intestinal colonization leading to fecal urobilinoid excretion may play a role in the pathogenesis of neonatal jaundice, J PED GASTR, 30(3), 2000, pp. 294-298
Authors:
Carreno, V
Zeuzem, S
Hopf, U
Marcellin, P
Cooksley, WGE
Fevery, J
Diago, M
Reddy, R
Peters, M
Rittweger, K
Rakhit, A
Pardo, M
Citation: V. Carreno et al., A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B, J HEPATOL, 32(2), 2000, pp. 317-324
Authors:
Van der Merwe, S
Dens, J
Daenen, W
Desmet, V
Fevery, J
Citation: S. Van Der Merwe et al., Pericardial disease is often not recognised as a cause of chronic severe ascites, J HEPATOL, 32(1), 2000, pp. 164-169
Authors:
Aertgeerts, B
Buntinx, F
Fevery, J
Ansoms, S
Citation: B. Aertgeerts et al., Is there a difference between CAGE interviews and written CAGE questionnaires?, ALC CLIN EX, 24(5), 2000, pp. 733-736
Authors:
Aertgeerts, B
Buntinx, F
Bande-Knops, J
Vandermeulen, C
Roelants, M
Ansoms, S
Fevery, J
Citation: B. Aertgeerts et al., The value of CAGE, CUGE, and AUDIT in screening for alcohol abuse and dependence among college freshmen, ALC CLIN EX, 24(1), 2000, pp. 53-57
Authors:
Clarysse, C
Fevery, J
Yap, SH
Citation: C. Clarysse et al., In vitro assays for drug testing: continuous cell lines, ACT GASTR B, 63(2), 2000, pp. 213-215
Authors:
Fevery, J
Citation: J. Fevery, Non-surgical treatment of hepatocellular carcinoma (HCC), ACT GASTR B, 63(2), 2000, pp. 233-235
Authors:
Omasta, AK
Nevens, F
Fevery, J
Citation: Ak. Omasta et al., Gene therapy to reduce portal hypertension: Possible bridge to liver transplantation, ACT CHIR B, 100(6), 2000, pp. 288-288
Authors:
Gong, ZJ
De Meyer, S
van Pelt, J
Hertogs, K
Depla, E
Soumillion, A
Fevery, J
Yap, SH
Citation: Zj. Gong et al., Transfection of a rat hepatoma cell line with a construct expressing humanliver annexin V confers susceptibility to hepatitis B virus infection, HEPATOLOGY, 29(2), 1999, pp. 576-584
Authors:
Van den Bruel, A
Fevery, J
Van Dorpe, J
Hofland, L
Bouillon, R
Citation: A. Van Den Bruel et al., Hormonal and volumetric long term control of a growth hormone-releasing hormone-producing carcinoid tumor, J CLIN END, 84(9), 1999, pp. 3162-3169
Authors:
El Atti, EA
Nevens, F
Bogaerts, K
Verbeke, G
Fevery, J
Citation: Ea. El Atti et al., Variceal pressure is a strong predictor of variceal haemorrhage in patients with cirrhosis as well as in patients with non-cirrhotic portal hypertension, GUT, 45(4), 1999, pp. 618-621
Authors:
Fevery, J
Citation: J. Fevery, Pigment gallstones in Crohn's disease, GASTROENTY, 116(6), 1999, pp. 1492-1494
Authors:
Brenard, R
Closon, M
Fevery, J
Hautekeete, M
Citation: R. Brenard et al., Is antiviral treatment (IFN alpha and/or Ribavirin) justified in cirrhosisrelated to hepatitis C virus? Jury opinion, ACT GASTR B, 61(4), 1998, pp. 436-437
Risultati:
1-24
|